Regulatory Approvals

FDA Approves Centanafadine for ADHD in Adults, Children Aged ≥ 6 Years

By

Regulatory Approvals — FDA Approves Centanafadine for ADHD in Adults, Children Aged ≥ 6 Years  HCP Live

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. July 27, 2026.

By

Related Post

Regulatory Approvals

FDA Approves Blood-Based Test for Colorectal Cancer Screening

Regulatory Approvals

FDA Approves First NDSRI for ADHD in Adults and Children

Regulatory Approvals

FDA Approves Perioperative Pembrolizumab-EV Regimen for MIBC

Financial News For All

Labor

More than 900 Mount Nittany Medical Center union workers begin 5-day strike

Labor

Second public defender union goes on strike

Labor

Bronx Defenders union walks off the job, joining ongoing strike of attorneys who represent court clients that can’t afford to pay

Regulatory Approvals

FDA approves new ADHD medication: 5 things to know